Redesigned Strategy for the Generic Injectable Pharmaceutical Landscape

A discussion on strategizing generic business processes to meet the needs of generic drug delivery as a pharmaceutical, R&D and regulatory leader.

West in collaboration with ETHealthworld.com present this roundtable discussion that features West's Sr. Director, Sales, Asia Pacific, Alagu Subramaniam AR. In the quest for the most effective generic injectable drugs, pharmaceutical manufacturers need to optimize various functions that orchestrate their products. These include R&D, supply chain, quality control, cost control, compliance, packaging, and logistics, among others. Following the COVID-19 pandemic, generic drug delivery needs have become more demanding in terms of time-to-market, price, and packaging.

How can pharmaceutical, R&D, and regulatory leaders strategize their generic business processes to meet all these needs seamlessly? Find the answers from the experts in this roundtable.